| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $83.1M | — | +20.2% |
| Cost of Revenue | $29.2M | — | +16.7% |
| Gross Profit | $53.9M | — | +22.2% |
| R&D Expense | $21.5M | — | +30.9% |
| SG&A Expense | $65.1M | — | +17.9% |
| Operating Income | -$32.6M | — | -18.8% |
| Pre-tax Income | -$31.7M | — | -27.8% |
| Income Tax | -$43K | — | +8.5% |
| Net Income | -$31.6M | — | -27.9% |
| EPS (Basic) | -$0.56 | — | -24.4% |
| EPS (Diluted) | -$0.56 | — | -24.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $245.6M | -14.3% | -22.3% |
| Accounts Receivable | $96.4M | +15.4% | +21.6% |
| Inventory | $77.5M | +9.7% | +24.4% |
| Current Assets | $428.0M | -5.0% | -8.1% |
| Total Assets | $487.1M | -4.1% | -6.2% |
| Current Liabilities | $63.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$38.1M | — | -124.5% |
| Capital Expenditures | $2.9M | — | +58.7% |
| Investing Cash Flow | -$2.9M | — | -58.7% |
| Financing Cash Flow | $222K | — | -82.9% |
| Free Cash Flow | -$41.0M | — | -118.1% |
| +22.2% |
| Long-term Debt | $51.7M | +0.1% | +0.3% |
| Total Liabilities | $139.4M | -2.0% | +7.0% |
| Stockholders' Equity | $347.7M | -5.0% | -10.7% |